Study finds fourth dose of Moderna or Pfizer vaccine provides “substantial” boost in COVID-19 immunity
A fourth dose is already authorized in the U.S. for people 50 and older.
Moderna
FDA encouraging Americans to get Pfizer or Moderna COVID-19 vaccines over J&J
New data shows COVID-19 hospitalizations and deaths are on track to rise for the first time in months, and the FDA is encouraging Americans to get either the Moderna or Pfizer vaccines over the Johnson & Johnson shot.
Moderna requests emergency use authorization for COVID-19 vaccine in young kids
Moderna requests emergency use authorization from the FDA for its vaccine for children as young as six-months-old.
Moderna seeks to be 1st with COVID shots for littlest kids
By Lauran Neergaard
Moderna is asking U.S. regulators to open its COVID-19 vaccine to the nation’s youngest children. Kids under 5 are the only group in the U.S. not yet eligible for vaccination.
Wednesday meeting provides no clear answers on future booster shot guidance
Health care providers hoping to get new guidance on coronavirus vaccines from the FDA will have to keep waiting. Wednesday’s meeting ended with no solid answers regarding the future of booster shots and regular vaccines.
Moderna says its low-dose COVID shots work for kids under 6
Moderna says its COVID-19 vaccine works in babies, toddlers and preschoolers.
Moderna announces full US approval for its COVID-19 vaccine
By Matthew Perrone
Moderna says U.S. health regulators have given full approval to its COVID-19 vaccine after reviewing additional data on its safety and effectiveness.
FDA shortens timing of Moderna booster to 5 months
U.S. regulators are shortening the time that people who received Moderna’s COVID-19 vaccine have to wait for a booster – to five months rather than six.
Omicron continues to spread as more hospitals are left overwhelmed
With omicron now detected in nearly every state, hospitals are left overwhelmed yet again. However, there is encouraging data from Moderna about its booster’s effectiveness against the highly transmissible variant.
Moderna: Initial booster data shows good results on omicron
Moderna said Monday that a booster dose of its COVID-19 vaccine should offer protection against the rapidly spreading omicron variant.
